Epic Corporation Share Price Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Sales 2008 | 22.12T 18.47L | Sales 2009 | 5.22T 4L | Capitalization | 6L 4.7Cr |
---|---|---|---|---|---|
Net income 2008 | - 0 | Net income 2009 | - 0 | EV / Sales 2008 | 33.3 x |
Net Debt 2008 | 4L 3.34Cr | Net Debt 2009 | 7L 5.62Cr | EV / Sales 2009 | 237 x |
P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 01/97/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 01/97/01 |
1st Jan change | Capi. | |
---|---|---|
+64.44% | 1.01TCr | |
+55.73% | 230.55Cr | |
+50.10% | 49Cr | |
-52.06% | 46Cr | |
+161.21% | 46Cr | |
-58.82% | 31Cr | |
-63.26% | 14Cr | |
-.--% | 12Cr | |
-32.20% | 9.69Cr |